Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy: Brief communication

American Journal of Transplantation

Volumn 9, Issue 7, 2009, Pages 1679-1684

  Brestrich, G ^a   Zwinger, S ^a   Fischer, A ^a   Schmuck M ^a   Rohmhild A ^a   Hammer, M H ^a   Kurtz, A ^a   Uharek, L ^a   Knosalla, C ^b   Lehmkuhl, H ^b   Volk, H D ^a   Reinke, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Cytomegalovirus (CMV); Cytomegalovirus infection; Solid organ transplant infections; Solid organ transplantation; T cells; T cell immunology; T cell therapy; Translational research; Transplant infectious diseases; Transplantation cell therapy

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOMEGALOVIRUS ANTIGEN PP65; FOSCARNET; GAMMA INTERFERON; GANCICLOVIR; IMMUNOGLOBULIN; INTERLEUKIN 2; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL LINE; CELL SPECIFICITY; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LUNG BIOPSY; LUNG TRANSPLANTATION; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECURRENT DISEASE; TREATMENT OUTCOME; VIRUS LOAD;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; EPITOPE MAPPING; GANCICLOVIR; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; RECURRENCE; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS; VIRUS REPLICATION;

EID: 67649635053     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02672.x     Document Type: Article

References (20)

1. Razonable RR, Rivero A, Rodriguez A et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001 184 : 1461 1464. (Pubitemid 33108862)
2. Crumpacker CS. Ganciclovir. N Engl J Med 1996 335 : 721 729.
3. Einsele H, Kapp M, Grigoleit GU. CMV-specific T cell therapy. Blood Cells Mol Dis 2008 40 : 71 75. (Pubitemid 350192309)
4. Hammer MH, Meyer S, Brestrich G et al. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy. Eur J Immunol 2005 35 : 2250 2258. (Pubitemid 41015064)
5. Kern F, Surel IP, Brock C et al. T-cell epitope mapping by flow cytometry. Nat Med 1998 4 : 975 978.
6. Andree H, Nickel P, Nasiadko C et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 2006 17 : 573 580.
7. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: Implications for vaccine design. Nat Rev Immunol 2008 8 : 247 258.
8. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 2007 81 : 8468 8476. (Pubitemid 47242819)
9. Appay V, Rowland-Jones SL. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol 2004 16 : 205 212. (Pubitemid 38569901)
10. + T cells. J Immunol 2002 169 : 5838 5843. (Pubitemid 35291687)
11. Sacre K, Carcelain G, Cassoux N et al. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med 2005 201 : 1999 2010. (Pubitemid 41002935)
12. + T cells in protection against CMV disease. Blood 2003 101 : 2686 2692. (Pubitemid 36857631)
13. Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474. (Pubitemid 40313337)
14. + regulatory T cells in hepatitis C virus infection. J Virol 2008 82 : 5043 5053. (Pubitemid 351657064)
15. + T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 2008 118 : 294 305.
16. Letsch A, Knoedler M, Na IK et al. CMV-specific central memory T cells reside in bone marrow. Eur J Immunol 2007 37 : 3063 3068. (Pubitemid 350131286)
17. Haque T, Wilkie GM, Jones MM et al. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: Results of a phase 2 multicenter clinical trial. Blood 2007 110 : 1123 1131. (Pubitemid 47281407)
18. Rooney CM, Smith CA, Ng CY et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998 92 : 1549 1555. (Pubitemid 28406858)
19. Savoldo B, Goss JA, Hammer MM et al. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood 2006 108 : 2942 2949. (Pubitemid 44776930)
20. Dudley ME, Wunderlich JR, Robbins PF et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002 298 : 850 854. (Pubitemid 35231542)